The Rise Crafters
  • Business
  • Investing
  • Stocks
  • World News
No Result
View All Result
  • Business
  • Investing
  • Stocks
  • World News
No Result
View All Result
The Rise Crafters
No Result
View All Result
Home Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

July 28, 2025
in Investing
RAD receives IND approval from US FDA for Betabart (RV-01)
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Previous Post

Maiden Drill Program Commences at Oasis Uranium Project

Next Post

Things are getting better at Boeing under CEO Ortberg, but can he keep it going?

Next Post
Things are getting better at Boeing under CEO Ortberg, but can he keep it going?

Things are getting better at Boeing under CEO Ortberg, but can he keep it going?

    Join our insider list and unlock access to members-only perks! Get the scoop on upcoming deals, tailored content, and unique promotions before anyone else. As part of our inner circle, you'll be the first to hear about exclusive rewards and limited-time invitations. Don’t miss out — become a valued member today!


    By subscribing, you consent to receive communications from us and trusted partners. We value your privacy and ensure your data remains safe and confidential.

    Recent News

    Crypto Market Update: Binance Eyes US Re-Entry After Trump Pardons Founder

    Crypto Market Update: Binance Eyes US Re-Entry After Trump Pardons Founder

    October 28, 2025
    PMET Releases Lithium-Only Feasibility Study for Shaakichiuwaanaan in Québec

    PMET Releases Lithium-Only Feasibility Study for Shaakichiuwaanaan in Québec

    October 28, 2025
    Altech Batteries LtdSodium Nickel Chloride Batteries Outstanding Safety Destructve Testing

    Altech Batteries LtdSodium Nickel Chloride Batteries Outstanding Safety Destructve Testing

    October 28, 2025
    Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth

    Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth

    October 28, 2025
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 therisecrafters.com | All Rights Reserved

    No Result
    View All Result
    • Business
    • Investing
    • Stocks
    • World News

    Copyright © 2025 therisecrafters.com | All Rights Reserved